Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of ACT-132577 on Midazolam PK in Healthy Males
NCT02841761Phase 1Completed
- Sponsor
- Idorsia
- Start
- Jul 2016
- Primary completion
- Sep 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of aprocitentan in resistant hypertension (RH), sponsored by Idorsia. Primary endpoints: Maximum observed plasma concentration at Day 7, Area under the plasma concentration-time curve from zero to infinity at Day 7 and 2 more. Started Jul 2016; status: completed.
02
Drugs
aprocitentan
03
Conditions
resistant hypertension (RH)
Beyond the preview
Go deeper on NCT02841761.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02841761.